Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Larimar Therapeutics, Inc. Common Stock

LRMR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of LRMR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
LRMR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
LRMR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
LRMR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in LRMR holdings by institutional investors

Quarterly net insider trading by LRMR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for LRMR

Quiver Logo

No former government officials on record as having lobbied for LRMR

Revolving Door Dashboard

LRMR Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

LRMR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
LRMR Income Statement
LRMR Balance Sheet
LRMR Cash Flow
U.S. Patents

New LRMR patent grants

  • Patent Title: Methods of quantifying frataxin and frataxin fusion proteins Mar. 03, 2026
  • Patent Title: Methods for quantifying frataxin activity Sep. 09, 2025
  • Patent Title: Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof Aug. 19, 2025
  • Patent Title: Molecules for organelle-specific protein delivery Jul. 08, 2025
  • Patent Title: Molecules for organelle-specific protein delivery Sep. 17, 2024
  • Patent Title: Methods for quantifying frataxin activity May. 21, 2024
  • Patent Title: Methods for treating myelin associated diseases and mitochondria associated diseases May. 07, 2024
  • Patent Title: Molecules for organelle-specific protein delivery Feb. 06, 2024
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to LRMR from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
LRMR News

Recent insights relating to LRMR

CNBC Recommendations

Recent picks made for LRMR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LRMR

LRMR Analyst Ratings

LRMR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
LRMR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $LRMR stock a Buy, Sell, or Hold?

  • What is the price target for $LRMR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

LRMR Top Shareholders
Shareholder
Shares Held
LRMR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $LRMR stock?

  • Who owns the most shares of $LRMR stock?

  • What funds own $LRMR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

LRMR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view LRMR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About LRMR

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

  • Address Bala Cynwyd, PA
  • Market Cap 401.5 million
  • Employees 71
  • Industrial Classification Pharmaceutical Preparations

Larimar Therapeutics, Inc. Common Stock (LRMR) Historical Stock Prices

Larimar Therapeutics, Inc. Common Stock (LRMR) closed at $3.87 on September 23, 2026. Over the past year its adjusted close ranged from $2.81 to $5.95. Daily prices go back to June 19, 2014, 3,084 trading days in all.

  • 1 month-4.57%
  • 3 months+6.47%
  • Year to date+1.44%
  • 1 year-12.95%
  • 3 years-7.98%
  • 5 years-68.91%
  • Max-80.43%
See every congressional and insider trade on the LRMR price chart

Quiver Premium charts LRMR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 3.82 3.90 3.71 3.87 3.87 2,718,706
Sep 22, 2026 3.91 3.96 3.81 3.82 3.82 702,937
Sep 21, 2026 3.84 3.88 3.78 3.83 3.83 579,330
Sep 18, 2026 3.81 3.88 3.75 3.79 3.79 1,641,201
Sep 17, 2026 3.93 4.12 3.80 3.80 3.80 1,196,103
Sep 16, 2026 3.93 3.97 3.83 3.93 3.93 1,957,895
Sep 15, 2026 3.86 3.94 3.70 3.91 3.91 856,618
Sep 14, 2026 3.93 3.98 3.74 3.78 3.78 1,169,128
Sep 11, 2026 3.91 4.07 3.85 3.92 3.92 2,127,479
Sep 10, 2026 3.82 3.86 3.74 3.85 3.85 871,387
Sep 9, 2026 4.03 4.17 3.83 3.87 3.87 978,795
Sep 8, 2026 3.76 4.08 3.72 4.08 4.08 1,040,647
Sep 4, 2026 3.82 3.85 3.79 3.83 3.83 391,990
Sep 3, 2026 3.90 3.90 3.77 3.83 3.83 684,259
Sep 2, 2026 3.96 4.08 3.82 3.87 3.87 515,555
Sep 1, 2026 3.78 3.95 3.77 3.94 3.94 755,350
Aug 31, 2026 3.98 4.00 3.81 3.82 3.82 1,066,012
Aug 28, 2026 4.03 4.08 3.98 4.01 4.01 641,505
Aug 27, 2026 4.16 4.16 4.02 4.05 4.05 673,588
Aug 26, 2026 4.14 4.18 4.02 4.17 4.17 702,135
Aug 25, 2026 4.08 4.24 4.08 4.16 4.16 1,082,141
Aug 24, 2026 4.23 4.23 3.93 4.05 4.05 945,554
Aug 21, 2026 4.20 4.21 4.08 4.18 4.18 699,420
Aug 20, 2026 4.21 4.21 3.98 4.16 4.16 1,157,960
Aug 19, 2026 4.19 4.34 4.17 4.25 4.25 1,232,364
Aug 18, 2026 4.31 4.35 4.05 4.06 4.06 869,633
Aug 17, 2026 4.33 4.42 4.30 4.32 4.32 882,799
Aug 14, 2026 4.26 4.39 4.17 4.36 4.36 1,183,071
Aug 13, 2026 4.38 4.46 4.23 4.27 4.27 1,502,798
Aug 12, 2026 4.31 4.40 4.28 4.37 4.37 1,180,764
Aug 11, 2026 4.04 4.38 4.02 4.31 4.31 1,655,941
Aug 10, 2026 4.15 4.29 4.00 4.01 4.01 1,396,783
Aug 7, 2026 4.24 4.28 4.08 4.16 4.16 631,188
Aug 6, 2026 4.19 4.31 4.14 4.20 4.20 759,754
Aug 5, 2026 4.11 4.29 4.08 4.10 4.10 1,281,053
Aug 4, 2026 3.98 4.14 3.82 4.11 4.11 1,681,528
Aug 3, 2026 3.83 4.00 3.74 3.98 3.98 793,828
Jul 31, 2026 3.82 3.86 3.71 3.82 3.82 1,059,290
Jul 30, 2026 3.65 3.90 3.60 3.83 3.83 1,033,101
Jul 29, 2026 3.81 3.90 3.62 3.63 3.63 1,795,107
Jul 28, 2026 3.84 3.86 3.68 3.83 3.83 1,778,866
Jul 27, 2026 4.00 4.06 3.81 3.83 3.83 1,744,060
Jul 24, 2026 4.03 4.16 3.98 4.00 4.00 1,230,995
Jul 23, 2026 4.01 4.10 3.93 4.01 4.01 698,871
Jul 22, 2026 3.90 4.17 3.90 4.02 4.02 1,311,421
Jul 21, 2026 3.83 3.98 3.74 3.93 3.93 970,092
Jul 20, 2026 3.76 3.90 3.73 3.83 3.83 1,396,461
Jul 17, 2026 3.61 3.79 3.60 3.70 3.70 1,389,140
Jul 16, 2026 3.80 3.80 3.54 3.67 3.67 1,336,205
Jul 15, 2026 3.73 3.83 3.56 3.81 3.81 1,269,914
Jul 14, 2026 3.74 3.82 3.58 3.72 3.72 1,842,147
Jul 13, 2026 4.19 4.22 3.70 3.73 3.73 2,297,804
Jul 10, 2026 4.12 4.32 3.85 4.28 4.28 3,445,587
Jul 9, 2026 3.84 4.28 3.79 4.13 4.13 3,823,933
Jul 8, 2026 3.42 3.64 3.41 3.61 3.61 2,063,889
Jul 7, 2026 3.35 3.45 3.21 3.41 3.41 1,741,701
Jul 6, 2026 3.29 3.38 3.26 3.29 3.29 1,750,854
Jul 2, 2026 3.22 3.38 3.15 3.26 3.26 2,443,968
Jul 1, 2026 3.04 3.25 3.01 3.21 3.21 2,610,528
Jun 30, 2026 3.12 3.21 2.96 3.05 3.05 3,199,747
Jun 29, 2026 2.99 3.30 2.92 3.20 3.20 13,429,906
Jun 26, 2026 3.52 3.67 3.23 3.66 3.66 9,106,785
Jun 25, 2026 3.63 3.79 3.49 3.50 3.50 1,775,193
Jun 24, 2026 3.69 3.79 3.61 3.63 3.63 1,568,839
Jun 23, 2026 3.63 3.86 3.61 3.68 3.68 1,977,820
Jun 22, 2026 3.65 3.77 3.61 3.66 3.66 1,852,891
Jun 18, 2026 3.62 3.76 3.48 3.64 3.64 3,301,187
Jun 17, 2026 3.42 3.85 3.40 3.54 3.54 2,224,247
Jun 16, 2026 3.59 3.66 3.39 3.40 3.40 926,176
Jun 15, 2026 3.52 3.64 3.48 3.59 3.59 1,670,476
Jun 12, 2026 3.60 3.73 3.43 3.47 3.47 1,563,039
Jun 11, 2026 3.45 3.64 3.44 3.60 3.60 3,394,853
Jun 10, 2026 3.47 3.67 3.42 3.44 3.44 3,228,006
Jun 9, 2026 3.17 3.51 3.12 3.50 3.50 3,067,849
Jun 8, 2026 3.21 3.25 3.04 3.10 3.10 1,467,284
Jun 5, 2026 3.25 3.26 3.12 3.17 3.17 1,239,630
Jun 4, 2026 3.23 3.35 3.15 3.29 3.29 1,693,262
Jun 3, 2026 3.29 3.29 3.18 3.20 3.20 1,852,429
Jun 2, 2026 3.47 3.48 3.30 3.30 3.30 1,827,147
Jun 1, 2026 3.50 3.63 3.42 3.51 3.51 2,209,605
May 29, 2026 3.50 3.53 3.42 3.48 3.48 1,293,736
May 28, 2026 3.51 3.57 3.43 3.49 3.49 999,775
May 27, 2026 3.61 3.67 3.47 3.52 3.52 1,709,665
May 26, 2026 3.49 3.56 3.40 3.47 3.47 921,000
May 22, 2026 3.60 3.66 3.42 3.45 3.45 1,126,324
May 21, 2026 3.45 3.58 3.40 3.57 3.57 1,516,762
May 20, 2026 3.35 3.53 3.32 3.53 3.53 1,927,419
May 19, 2026 3.25 3.41 3.21 3.33 3.33 1,978,794
May 18, 2026 3.58 3.65 3.21 3.24 3.24 2,391,724
May 15, 2026 3.85 3.87 3.55 3.58 3.58 3,491,959
May 14, 2026 4.14 4.15 3.44 3.89 3.89 3,647,385
May 13, 2026 4.09 4.16 4.03 4.10 4.10 822,744
May 12, 2026 4.08 4.21 4.04 4.13 4.13 912,367
May 11, 2026 4.00 4.21 3.97 4.09 4.09 1,826,515
May 8, 2026 4.02 4.20 3.94 3.97 3.97 1,496,786
May 7, 2026 4.12 4.12 3.85 4.00 4.00 1,557,217
May 6, 2026 4.05 4.28 4.00 4.15 4.15 2,415,144
May 5, 2026 4.23 4.29 4.00 4.01 4.01 1,952,378
May 4, 2026 3.93 4.29 3.88 4.22 4.22 2,144,079
May 1, 2026 4.04 4.12 3.89 3.94 3.94 2,193,308
Apr 30, 2026 4.33 4.37 4.03 4.06 4.06 1,484,406
Apr 29, 2026 4.36 4.38 4.19 4.34 4.34 1,570,460
Apr 28, 2026 4.45 4.47 4.33 4.40 4.40 1,406,255
Apr 27, 2026 4.55 4.66 4.37 4.44 4.44 1,396,010
Apr 24, 2026 4.50 4.58 4.44 4.54 4.54 1,107,283
Apr 23, 2026 4.54 4.60 4.37 4.50 4.50 1,201,919
Apr 22, 2026 4.60 4.67 4.47 4.56 4.56 1,000,633
Apr 21, 2026 4.82 4.83 4.54 4.57 4.57 963,306
Apr 20, 2026 4.77 4.82 4.66 4.81 4.81 896,572
Apr 17, 2026 4.81 4.87 4.71 4.80 4.80 900,333
Apr 16, 2026 4.83 4.84 4.67 4.72 4.72 1,186,952
Apr 15, 2026 4.87 5.00 4.78 4.83 4.83 1,766,998
Apr 14, 2026 4.91 4.97 4.83 4.87 4.87 1,114,647
Apr 13, 2026 4.85 5.04 4.69 4.86 4.86 1,438,914
Apr 10, 2026 5.11 5.14 4.78 4.85 4.85 1,898,866
Apr 9, 2026 5.09 5.18 4.98 5.09 5.09 1,401,885
Apr 8, 2026 5.26 5.35 5.05 5.09 5.09 1,322,381
Apr 7, 2026 4.99 5.16 4.83 5.04 5.04 1,087,690
Apr 6, 2026 4.79 5.11 4.72 5.05 5.05 2,007,125
Apr 2, 2026 4.57 4.80 4.51 4.79 4.79 994,381
Apr 1, 2026 4.58 4.82 4.58 4.68 4.68 1,842,151
Mar 31, 2026 4.40 4.65 4.40 4.50 4.50 1,750,908
Mar 30, 2026 4.58 4.63 4.21 4.31 4.31 1,153,745
Mar 27, 2026 4.82 4.84 4.56 4.62 4.62 1,044,826
Mar 26, 2026 4.59 4.85 4.58 4.85 4.85 1,200,943
Mar 25, 2026 4.59 4.83 4.57 4.68 4.68 4,524,736
Mar 24, 2026 4.59 4.67 4.47 4.57 4.57 1,932,574
Mar 23, 2026 4.56 4.79 4.50 4.68 4.68 1,925,433
Mar 20, 2026 4.52 4.92 4.41 4.49 4.49 2,844,320
Mar 19, 2026 4.27 4.67 4.20 4.47 4.47 2,445,298
Mar 18, 2026 4.40 4.41 4.24 4.30 4.30 1,119,677
Mar 17, 2026 4.40 4.50 4.30 4.38 4.38 1,422,804
Mar 16, 2026 4.69 4.78 4.35 4.40 4.40 2,329,739
Mar 13, 2026 4.87 5.01 4.45 4.59 4.59 3,841,977
Mar 12, 2026 5.41 5.41 4.75 4.77 4.77 2,725,917
Mar 11, 2026 5.61 5.74 5.39 5.42 5.42 1,422,103
Mar 10, 2026 5.81 6.00 5.50 5.61 5.61 2,502,736
Mar 9, 2026 5.18 5.75 5.16 5.69 5.69 3,552,878
Mar 6, 2026 5.08 5.26 4.94 5.22 5.22 1,851,820
Mar 5, 2026 5.36 5.55 5.18 5.22 5.22 2,306,261
Mar 4, 2026 5.53 5.73 5.32 5.45 5.45 3,093,397
Mar 3, 2026 5.58 5.68 5.21 5.51 5.51 3,494,495
Mar 2, 2026 5.03 5.35 4.92 5.23 5.23 2,360,583
Feb 27, 2026 5.54 5.67 5.19 5.31 5.31 4,318,175
Feb 26, 2026 5.40 5.76 5.20 5.52 5.52 12,955,609
Feb 25, 2026 3.66 6.42 3.65 5.95 5.95 81,028,325
Feb 24, 2026 3.59 4.01 3.55 3.69 3.69 70,424,355
Feb 23, 2026 2.96 3.00 2.71 2.81 2.81 908,322
Feb 20, 2026 3.06 3.07 2.90 2.97 2.97 873,855
Feb 19, 2026 2.92 3.12 2.89 3.11 3.11 649,452
Feb 18, 2026 3.01 3.10 2.93 2.95 2.95 898,691
Feb 17, 2026 3.15 3.18 2.96 3.03 3.03 1,269,246
Feb 13, 2026 3.22 3.28 3.15 3.15 3.15 442,420
Feb 12, 2026 3.36 3.40 3.18 3.21 3.21 446,617
Feb 11, 2026 3.34 3.38 3.20 3.34 3.34 770,024
Feb 10, 2026 3.40 3.48 3.31 3.33 3.33 562,000
Feb 9, 2026 3.38 3.46 3.25 3.39 3.39 666,484
Feb 6, 2026 3.13 3.40 3.11 3.37 3.37 1,091,614
Feb 5, 2026 3.26 3.32 3.06 3.07 3.07 1,502,158
Feb 4, 2026 3.42 3.45 3.22 3.28 3.28 1,634,783
Feb 3, 2026 3.51 3.61 3.38 3.45 3.45 657,971
Feb 2, 2026 3.50 3.60 3.42 3.51 3.51 727,467
Jan 30, 2026 3.54 3.67 3.47 3.54 3.54 853,699
Jan 29, 2026 3.66 3.66 3.52 3.57 3.57 724,543
Jan 28, 2026 3.70 3.76 3.56 3.68 3.68 1,307,423
Jan 27, 2026 3.58 3.72 3.50 3.67 3.67 891,810
Jan 26, 2026 3.64 3.64 3.44 3.60 3.60 3,252,932
Jan 23, 2026 3.43 3.72 3.37 3.69 3.69 3,036,564
Jan 22, 2026 3.33 3.62 3.31 3.45 3.45 1,003,502
Jan 21, 2026 3.20 3.38 3.20 3.32 3.32 571,301
Jan 20, 2026 3.08 3.27 3.05 3.20 3.20 853,272
Jan 16, 2026 3.27 3.39 3.08 3.13 3.13 1,617,128
Jan 15, 2026 3.42 3.47 3.24 3.26 3.26 824,576
Jan 14, 2026 3.31 3.62 3.30 3.41 3.41 1,619,972
Jan 13, 2026 3.23 3.40 3.21 3.33 3.33 882,815
Jan 12, 2026 3.35 3.35 3.12 3.25 3.25 1,764,435
Jan 9, 2026 3.40 3.50 3.31 3.33 3.33 734,030
Jan 8, 2026 3.39 3.45 3.33 3.36 3.36 681,806
Jan 7, 2026 3.37 3.52 3.31 3.42 3.42 1,311,480
Jan 6, 2026 3.36 3.46 3.35 3.37 3.37 872,932
Jan 5, 2026 3.49 3.52 3.31 3.36 3.36 1,275,131
Jan 2, 2026 3.76 3.77 3.43 3.47 3.47 1,429,348
Dec 31, 2025 3.89 3.94 3.72 3.81 3.81 910,401
Dec 30, 2025 3.98 3.98 3.85 3.91 3.91 494,091
Dec 29, 2025 3.89 4.00 3.86 3.96 3.96 541,729
Dec 26, 2025 3.95 4.00 3.86 3.93 3.93 740,419
Dec 24, 2025 3.91 4.04 3.90 3.97 3.97 551,105
Dec 23, 2025 3.96 3.96 3.79 3.91 3.91 1,186,478
Dec 22, 2025 3.64 4.05 3.55 4.00 4.00 1,533,794
Dec 19, 2025 3.42 3.73 3.38 3.65 3.65 1,633,852
Dec 18, 2025 3.50 3.60 3.38 3.43 3.43 1,773,153
Dec 17, 2025 3.74 3.87 3.34 3.46 3.46 2,836,270
Dec 16, 2025 3.88 3.90 3.73 3.74 3.74 928,511
Dec 15, 2025 4.10 4.15 3.90 3.92 3.92 943,904
Dec 12, 2025 4.01 4.09 3.89 4.05 4.05 682,880
Dec 11, 2025 3.97 4.09 3.89 4.02 4.02 1,210,690
Dec 10, 2025 4.03 4.09 3.81 3.94 3.94 1,277,080
Dec 9, 2025 3.73 4.04 3.73 4.03 4.03 1,102,390
Dec 8, 2025 3.76 3.92 3.71 3.82 3.82 837,548
Dec 5, 2025 3.72 3.80 3.66 3.70 3.70 623,670
Dec 4, 2025 3.43 3.75 3.36 3.68 3.68 1,012,583
Dec 3, 2025 3.20 3.49 3.13 3.47 3.47 1,377,085
Dec 2, 2025 3.56 3.56 3.12 3.12 3.12 2,726,869
Dec 1, 2025 3.48 3.69 3.40 3.55 3.55 3,348,914
Nov 28, 2025 3.57 3.62 3.52 3.54 3.54 813,815
Nov 26, 2025 3.68 3.73 3.52 3.53 3.53 3,072,062
Nov 25, 2025 3.64 3.79 3.60 3.67 3.67 1,503,405
Nov 24, 2025 3.52 3.68 3.51 3.66 3.66 520,288
Nov 21, 2025 3.34 3.63 3.32 3.56 3.56 1,153,661
Nov 20, 2025 3.55 3.68 3.33 3.37 3.37 1,336,048
Nov 19, 2025 3.38 3.52 3.32 3.47 3.47 2,617,702
Nov 18, 2025 3.49 3.64 3.37 3.39 3.39 1,410,600
Nov 17, 2025 3.38 3.62 3.31 3.53 3.53 1,103,376
Nov 14, 2025 3.25 3.46 3.22 3.38 3.38 723,333
Nov 13, 2025 3.33 3.39 3.23 3.29 3.29 1,294,883
Nov 12, 2025 3.62 3.69 3.34 3.37 3.37 2,068,778
Nov 11, 2025 3.47 3.72 3.39 3.63 3.63 1,289,942
Nov 10, 2025 3.57 3.62 3.46 3.55 3.55 1,187,472
Nov 7, 2025 3.42 3.48 3.21 3.46 3.46 1,455,702
Nov 6, 2025 3.19 3.56 3.18 3.47 3.47 2,333,374
Nov 5, 2025 3.64 3.64 3.16 3.22 3.22 4,967,085
Nov 4, 2025 3.77 3.90 3.71 3.80 3.80 1,067,457
Nov 3, 2025 3.86 4.06 3.76 3.88 3.88 1,055,483
Oct 31, 2025 4.04 4.16 3.88 3.89 3.89 1,134,944
Oct 30, 2025 4.20 4.42 4.01 4.04 4.04 1,046,169
Oct 29, 2025 4.36 4.50 4.26 4.31 4.31 1,372,850
Oct 28, 2025 4.35 4.48 4.20 4.35 4.35 1,270,534
Oct 27, 2025 4.26 4.36 4.14 4.34 4.34 796,207
Oct 24, 2025 4.00 4.33 3.98 4.21 4.21 1,549,162
Oct 23, 2025 3.94 4.00 3.87 3.95 3.95 1,796,366
Oct 22, 2025 4.24 4.30 3.88 3.93 3.93 2,415,364
Oct 21, 2025 4.40 4.46 4.18 4.29 4.29 1,886,393
Oct 20, 2025 4.35 4.47 4.20 4.35 4.35 1,693,029
Oct 17, 2025 4.22 4.30 4.07 4.20 4.20 1,276,155
Oct 16, 2025 4.28 4.53 4.20 4.26 4.26 2,029,919
Oct 15, 2025 3.92 4.26 3.90 4.24 4.24 1,629,539
Oct 14, 2025 4.16 4.21 3.88 3.90 3.90 1,880,044
Oct 13, 2025 4.41 4.41 4.04 4.25 4.25 2,127,248
Oct 10, 2025 4.53 4.54 4.17 4.36 4.36 2,650,197
Oct 9, 2025 4.78 4.84 4.55 4.55 4.55 3,726,895
Oct 8, 2025 4.77 4.99 4.60 4.82 4.82 3,420,491
Oct 7, 2025 4.79 4.84 4.51 4.72 4.72 4,012,440
Oct 6, 2025 4.91 5.00 4.53 4.81 4.81 3,648,347
Oct 3, 2025 4.28 4.88 4.28 4.87 4.87 5,730,290
Oct 2, 2025 4.22 4.48 4.18 4.28 4.28 4,359,550
Oct 1, 2025 3.23 4.40 3.18 4.15 4.15 13,787,911
Sep 30, 2025 3.33 3.50 3.17 3.23 3.23 6,458,169
Sep 29, 2025 3.56 4.00 3.10 3.38 3.38 23,784,277
Sep 26, 2025 4.89 5.37 4.89 5.09 5.09 3,754,693
Sep 25, 2025 5.08 5.17 4.53 4.86 4.86 2,955,938
Sep 24, 2025 4.38 5.21 4.26 5.10 5.10 7,809,139
Sep 23, 2025 4.47 4.63 4.41 4.44 4.44 1,904,498

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Larimar Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at LRMR, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation